Real-time enrollment status for this nasolacrimal duct obstruction clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 7:19 PM UTC
| NCT Number | NCT05999630 |
| Recruiting Status | Recruiting |
| Condition | Nasolacrimal Duct Obstruction |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Vanderbilt University Medical Center |
| Last Updated on CT.gov | October 28, 2025 (Oct 28, 2025) |
As of August 31, 2026: Clinical trial NCT05999630 is currently recruiting participants. This phase3 study for nasolacrimal duct obstruction is actively seeking new participants at 1 location across the United States. The study is sponsored by Vanderbilt University Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05999630 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05999630 was last updated Oct 28, 2025 (October 28, 2025). HelloStudys verifies this status automatically.